Introduction
============

The optimal treatment for severe coronary artery disease remains coronary artery bypass grafting (CABG).[@R1] Differences in the patency rates of various vascular conduits including internal mammary artery (IMA) and saphenous vein (SV) and the resulting difference in patient survival when differing grafting strategies are utilized have long been recognized.[@R2]--[@R4] The specific factors which govern this discrepancy are not fully understood; however, the risk factors for ischaemic heart disease are believed to contribute ([**Fig. 1**](#F1){ref-type="fig"}).[@R5],[@R6] The endothelium has long been known to play a pivotal role in the regulation of vascular tone and homeostasis,[@R7] producing a wide array of vasoactive compounds. The ability of the conduits to adapt to oxidative stress associated with the excessive bioavailability of reactive oxygen species (ROS) is also believed to be important.[@R8]--[@R12] The interaction between risk factor status and abnormal levels of ROS is at best complex, with 17-β-estradiol eliciting vasodilatation,[@R13] and diabetes having no effect on endothelial responses in some studies[@R14] although changes have been demonstrated in the levels of superoxide (O~2~^.-^) produced by diabetic subjects. Smoking has been shown to reduce levels of nitric oxide (NO), but this was associated with increased production of nitric oxide synthase.[@R15] Manipulation of H~2~O~2~ levels has been shown to produce opposite effects at differing concentration by the same group.[@R16],[@R17]

Vascular reactivity has long been utilized as a marker of endothelial function,[@R18],[@R19] and this concept underpins our investigation methodology. Using isometric tension studies in human vascular samples, we sought to investigate the two commonly used CABG conduits. Our aim was to delineate if there was a correlation between the type and presence of risk factors and endothelial responses in these conduits.

Endothelium-dependent vasomotion is generally accepted as being reflective of the overall function of the endothelium,[@R20] and is considered to be an early marker of atherosclerosis.[@R21] A direct link between vascular responses to acetylcholine and long term outlook had been demonstrated,[@R22] therefore we chose acetylcholine to interrogate vascular responses dependent upon the endothelium. Sodium nitroprusside is a NO donor which directly affects the vascular smooth muscle, irrespective of whether the endothelium is functional,[@R23] and it was used to elicit vascular responses independent of the endothelium.

Results
=======

Patient characteristics.
------------------------

Of the 126 patients, 103 were male, 33 had diabetes mellitus and 67 were hypertensive, with 24 current and 62 ex-smokers. There was no significant difference between the ages of male (median 66y) and female (median 68y) patients ([**Table 1**](#T1){ref-type="table"}). These patients contributed a total of 449 vascular segments (212 IMA).

Conduit influence.
------------------

Endothelium-dependent relaxant responses were greater in IMA than SV with maximal responses being 53.12 ± 2.13% and 35.47 ± 2.13%, respectively (p \< 0.05, [**Fig. 2A**](#F2){ref-type="fig"}). Similarly, endothelium-independent relaxant responses were greater in IMA (117.30 ± 1.64% versus 101.86 ± 1.56%, p \< 0.05, [**Fig. 2B**](#F2){ref-type="fig"}). Contractions to high potassium solution were significantly greater with IMA than SV (938.3 ± 42.4 g versus 724.7 ± 38.7 g per g dry tissue, n ≥ 50, p \< 0.05).

Risk factor influence.
----------------------

Endothelium-dependent relaxant responses were significantly better in male compared to female patients with both IMA and SV (p \< 0.05, [**Fig. 3A**](#F3){ref-type="fig"}), whilst the endothelium-independent relaxant responses were significantly better in SV segments from male patients (p \< 0.05) but not IMA segments (p \> 0.05, [**Fig. 3B**](#F3){ref-type="fig"}).

Of the 126 patients included for analysis, 125 were on lipid modifying medication (119 were on a statin), so meaningful analysis in relation to this risk factor was not possible. With both conduits, there were no differences in endothelium-dependent relaxant responses between diabetic and non-diabetic patients (IMA, p \> 0.05; SV, p \> 0.05, [**Fig. 4A**](#F4){ref-type="fig"}). In SV segments, however, the endothelium-independent relaxant responses of diabetic patients were significantly better than the responses of non-diabetic patients (p \< 0.05, [**Fig. 4B**](#F4){ref-type="fig"}).

In hypertensive patients, although no significant differences were observed in IMA endothelium-dependent relaxant responses, reduced relaxation was noted in SV specifically with the highest concentration of acetylcholine (p \< 0.05, [**Fig. 5A**](#F5){ref-type="fig"}). With both conduits, there were no differences in endothelium-independent relaxant responses between hypertensive and non-hypertensive patients ([**Fig. 5B**](#F5){ref-type="fig"}).

The relationship between smoking history and relaxant responses is complex. In IMA segments, current smokers have the worst endothelium-dependent responses, ex-smokers next and non-smokers the best (p \< 0.05). The opposite is true for SV segments, with non-smokers having the worst endothelium-dependent responses, ex-smokers next and current smokers the best (p \< 0.05). In IMA segments, there were no differences in the endothelium-independent relaxant responses (p \> 0.05), however, in SV segments, ex-smokers have the worst endothelium-independent responses, non-smokers next and current smokers the best (p \< 0.05). Responses in current versus non-smokers are seen in [**Figure 6A**](#F6){ref-type="fig"} (endothelium-dependent: both IMA and SV p \< 0.05) and [**6B**](#F6){ref-type="fig"} (endothelium-independent: both IMA and SV p \> 0.05). Responses in current versus ex-smokers are seen in [**Figure 7A**](#F7){ref-type="fig"} (endothelium-dependent: IMA p \< 0.05) and [**7B**](#F7){ref-type="fig"} (endothelium-independent: IMA p \> 0.05, SV p \< 0.05).

There were no significant differences in the contractile function of each conduit with respect to each risk factor. For example, with IMA segments, hypertensives gave 917.7 ± 486.1 g versus 968.8 ± 474.4 g per g of dry conduit. With SV segments, diabetics gave 640.6 ± 293.3 g versus 749.2 ± 434.3 g per g of dry conduit.

Discussion
==========

This study explicitly demonstrates that both the endothelium-dependent and independent relaxant responses of IMA segments are greater than the relaxant responses of SV segments. This is widely described in the literature[@R8],[@R12] and merely serves as the start-point for investigating which particular mechanisms are responsible for this response.

Gender has been shown to be an independent risk factor for long term adverse outcomes following CABG,[@R24] with female patients being older and having a greater incidence of risk factors. Women have a lower incidence of coronary artery disease than men of comparable age, with oestrogen seemingly being the protective agent.[@R13],[@R25] For a woman to develop coronary disease of adequate severity to require CABG, it is likely that she has to have a greater risk factor burden than a man of comparable age. Enhanced endothelium-dependent relaxant responses in male as compared to female subjects has been previously reported,[@R26],[@R27] but is not universal,[@R28] however, no studies are available comparing endothelium-independent relaxant responses in male versus female patients. We have demonstrated that both endothelium-dependent and -independent relaxant responses are worse in female patients\' SV samples when compared to their male counterparts. With IMA segments, there was a difference in endothelium-dependent relaxant responses but no difference in endothelium-independent relaxant responses. Together, these data reveal that the gender difference between conduits is due solely to the endothelium with IMA segments, but both endothelium and smooth muscle levels for SV segments. These data uncover a further mechanism that may explain the poorer outcomes of CABG in female patients.

We have demonstrated that hypertension has no effect on endothelium-dependent responses in IMA. This lack of effect in IMA has been demonstrated before,[@R29] however other authors have noted decreased endothelial responses in the presence of hypertension.[@R30] There are few available vascular reactivity data to which we can compare our SV results, with many authors[@R31]--[@R35] concentrating upon particular facets of SV response utilising specific chemicals. Although not looking specifically at hypertension per se, Al-Benna and colleagues demonstrated reduced endothelial responses in SV obtained from coronary artery disease patients compared with control subjects.[@R36] The demographic data from their paper shows that the groups were similar except for hypertension and cholesterol level. Therefore, one can conclude that the differences between the control and study patients\' SV endothelial responses may be in part due to hypertension and hypercholesterolaemia. Hypertension is associated with increased oxidative stress, caused by either increased activity of oxidant enzymes, and/or dysfunction of anti-oxidant enzymes.[@R37],[@R38]

There are no differences in endothelium-dependent relaxant responses due to presence of diabetes in either conduit despite the extensive array of potential mechanisms affected, such as a reduction in NO production, overproduction of ROS, reduced levels of antioxidants, increased protein glycosylation and enhanced glucose auto-oxidation.[@R7] These data are at odds with some authors,[@R5],[@R39] but in agreement with others.[@R14] The data pertaining to endothelial (dys)function in diabetic subjects is contradictory, with increased, unchanged and even reduced levels of NO being reported.[@R7],[@R40] There are worsened endothelium-independent responses with non-diabetic as compared to diabetic patients. This effect has not been demonstrated before, the typical data in the literature showing no differences in responses.[@R14] We have demonstrated that a given risk factor per se may have a unique effect on vascular relaxation by impairing mechanisms at either endothelial or vascular smooth muscle cell level or a combination of both.

The effect smoking status has on the endothelial responses of the IMA was as expected from the literature, with a reduction in response with increased exposure to inhaled tobacco smoke, and in line with what is seen in the post-operative phase.[@R41] The endothelial responses in SV segments were contrary to that expected, and at odds with the behaviour of SV bypass grafts in the post-CABG phase.[@R42],[@R43] There are few data available concerning endothelium-independent conduit responses to smoking, and that data which does exist is contradictory.[@R44],[@R45] Clearly there is a more complex relationship between smoking status and vascular function than simple direct injury. A possible explanation is that there is upregulation of anti-oxidant capacity in the SV exposed to the various toxins[@R15] in tobacco smoke, which, in the controlled environment of the organ bath, without the usual chronic stimuli, may result in superior responses. Cigarette smoke has been shown to promote endothelial regeneration in a rat aortic model[@R46] and this accelerated endothelial repair may account for the responses in SV segments. This is at odds with other groups who have shown decreased migration of cultured human umbilical vein endothelial cells with exposure to cigarette smoke.[@R47],[@R48]

The contractile function of IMA conduits is greater than that of SV conduits when indexed to the conduit size. This is as anticipated, as the IMA is an elastic artery in its proximal course, but more distally where the samples are harvested from, its composition changes to be a muscular artery, termed a 'transition artery',[@R49] whilst there is only a modest smooth muscle layer present in the SV wall. With a greater proportion of muscle fibres per unit length of conduit, greater forces can be exerted. This ability to contract more strongly does not affect the relaxant responses of IMA conduits, indicating that the important determinant in conduit function is the endothelium, rather than the magnitude of smooth muscle.

Our current data reveal that vascular responses are affected by risk factor status, and this occurs at both the endothelial and smooth muscle levels. These patients were also involved in a range of investigations utilising a number of enzyme inhibitors, ROS-scavengers and second-messenger pathway inhibitors.[@R50] Collectively, these data indicate that a number of ROS (particularly O~2~^.-^) and the interaction between endothelium and smooth muscle is important in the regulation of overall vascular tone, with certain effects being seen at the endothelial level, and others at the vascular smooth muscle level.

Limitations of the study.
-------------------------

This investigation has looked at the functional responses of vascular conduits, but no investigation of protein levels, enzyme activity or mRNA expression of the appropriate oxidant and anti-oxidant enzymes has been undertaken. In situations where an unexpected reactivity response has been found, there may well be a simple explanation were these data available.

This investigation focuses solely on two bypass conduits, and does not include the responses in radial arteries. This was due to inadequate numbers of available patient samples.

Materials and Methods
=====================

Patients.
---------

Overall, 126 patients undergoing non-emergency coronary artery bypass grafting were recruited for this study. This study had the approval of the local Research Ethics Committee (Queen\'s University of Belfast) and all patients gave their written informed consent. Vascular samples were harvested from the operating theatres prior to pressure testing of each vessel, thereby avoiding distension injury, and all experiments were commenced within 1 hour of conduit harvest.

Risk factors.
-------------

Patients were grouped according to their risk factor status concentrating on 4 particular areas: a documented history of hypertension, defined as greater than 140/90 mmHg; the presence or absence of diabetes mellitus, defined as a fasting plasma glucose level greater than 7 mmol/l or 11.1 mmol/l following a glucose load (tolerance test); smoking history with current smoking being defined as having consumed inhaled tobacco smoke within 3 months of operation; and hypercholesterolaemia, with the cut-off point being defined as a total cholesterol ≥5.2 mmol/l.

Vascular reactivity.
--------------------

Vascular samples were dissected free of their surrounding tissues in an atraumatic fashion and sharply divided into 2--3 mm rings. Following calibration of the data acquisition system, these rings were individually mounted between triangular stirrups from isometric force transducers in an 8-bath organ chamber system under physiological conditions in Krebs buffer solution containing (all in mmol/l): NaCl 118.3, KCl 4.7, MgSO~4~ 1.2, KH~2~PO~4~ 1.2, CaCl 2.5, NaHCO~3~ 25, Glucose 11.1, pH 7.4, at 37°C. The solution was gassed with a 95% O~2~, 5% CO~2~ mix. Data were captured from these transducers via an 8-channel data acquisition system (ML780), and recorded in Chart v4 (ADinstruments Ltd., UK). After mounting, the vascular rings were allowed to equilibrate under tension for 90 minutes, with IMA segments being placed under 2.5 g of tension and SV segments under 1.5 g of tension.

The first process was to produce a contraction-concentration curve. The vessels were contracted with phenylephrine (0.001 to 30 µmol/l). Following a washout period, where the vessels returned to baseline tension, a sub-maximal dose was administered, to produce a plateau of contraction. From this plateau of contraction, ten acetylcholine doses (0.001 to 30 µmol/l) were added in a stepwise fashion, eliciting endothelium-dependent relaxant responses. This reagent was used to interrogate risk-factor influence in line with its wide utilisation within the literature. A second washout period then followed. Next, the process was repeated with sodium nitroprusside to demonstrate the contribution direct stimulation of the vascular smooth muscle cells has in these different conduits, with potentially different populations of smooth muscle cells. Eight stepwise doses (0.001 to 3 µmol/l) of this commonly used reagent within the vascular reactivity field assessed endothelium-independent relaxant responses. Following a final washout period, the vascular rings were subjected to a high potassium concentration (120 mmol/l) to directly stimulate the smooth muscle, bypassing all pathways, and confirming viability of the sample. The rings were air-dried overnight, and then weighed to index their contractions.

Statistical analysis.
---------------------

Analysis of relaxant responses was undertaken using repeated measures two-way ANOVA in all cases, with risk factor comparisons being unpaired. The relaxant responses analyses were performed using Prism v4 for Windows (GraphPad Software, San Diego, CA).
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![Schematic of the various factors with influence on the vascular endothelium as pertains to coronary artery bypass grafting.](oxim0303_0199_fig001){#F1}

![Endothelium-dependent (A) and -independent (B) relaxant responses are significantly greater in both internal mammary arteries (IMA; p \< 0.05, n = 89) and saphenous veins (SV; p \< 0.05, n = 92). Vessel segments are pre-contracted to a plateau using a sub-maximal dose of phenylephrine, then exposed to increasing concentrations of an endothelium-dependent (acetylcholine) or -independent (sodium nitroprusside) relaxant. Comparisons are made using paired repeated measures 2-way ANOVA and individual dose points are compared using Bonferroni post-hoc testing, with the indicated doses being significantly different from one another (p \< 0.05). Results are expressed as mean ± SEM.](oxim0303_0199_fig002){#F2}

![Endothelium-dependent relaxant responses (A) in internal mammary artery (IMA) and saphenous vein (SV) with male (n = 103) versus female (n = 23) patients, and endothelium-independent relaxant responses (B) in IMA and SV with male (n = 65) versus female (n = 11) patients are displayed. Vessel segments are pre-contracted to a plateau using a sub-maximal dose of phenylephrine, then exposed to increasing concentrations of an endothelium-dependent (acetylcholine) or -independent (sodium nitroprusside) relaxant. Comparisons are made using unpaired repeated measures 2-way ANOVA and individual dose points are compared using Bonferroni post-hoc testing, with the indicated doses being significantly different from one another (p \< 0.05, compared to the other sex). Differences in individual data points with IMA segments are noted below the curves, whilst differences with SV segments are indicated above the curves. Both IMA and SV endothelium-dependent relaxant responses are significantly better in male compared to female patients (p \< 0.05, A). Endothelium-independent relaxant responses of SV are significantly better in male versus female patients (p \< 0.05, B) whilst no significant differences are observed with IMA segments. Results are expressed as mean ± SEM.](oxim0303_0199_fig003){#F3}

![Endothelium-dependent relaxant responses (A) in internal mammary artery (IMA) and saphenous vein (SV) with diabetic (n = 33) versus non-diabetic (n = 93) patients, and endothelium-independent relaxant responses (B) in IMA and SV with diabetic (n = 20) versus non-diabetic (n = 55) patients are displayed. Vessel segments are pre-contracted to a plateau using a sub-maximal dose of phenylephrine, then exposed to increasing concentrations of an endothelium-dependent (acetylcholine) or -independent (sodium nitroprusside) relaxant. Comparisons are made using unpaired repeated measures 2-way ANOVA and individual dose points are compared using Bonferroni post-hoc testing, with the indicated doses being significantly different from one another (p \< 0.05, compared to the other group). The individual data point difference with SV segments is noted above the curve (B). There are no significant differences in endothelium-dependent relaxant responses with either conduit (both p \> 0.05, a). Endothelium-independent relaxant responses of SV are significantly better in diabetic versus non-diabetic patients (p \< 0.05, B) whilst no significant differences are observed with IMA segments. Results are expressed as mean ± SEM.](oxim0303_0199_fig004){#F4}

![Endothelium-dependent relaxant responses (A) in internal mammary artery (IMA) and saphenous vein (SV) with hypertensive (n = 67) versus non-hypertensive (n = 59) patients, and endothelium-independent relaxant responses (B) in IMA and SV with hypertensive (n = 40) versus non-hypertensive (n = 34) patients are displayed. Vessel segments are pre-contracted to a plateau using a sub-maximal dose of phenylephrine, then exposed to increasing concentrations of an endothelium-dependent (acetylcholine) or -independent (sodium nitroprusside) relaxant. Comparisons are made using unpaired repeated measures 2-way ANOVA and individual dose points are compared using Bonferroni post-hoc testing, with the indicated doses being significantly different from one another (p \< 0.05, compared to the other group). The individual data point difference with SV segments is noted above the curve (A). Endothelium-dependent relaxant responses of SV are significantly better in non-hypertensive versus hypertensive patients (p \< 0.05, A) whilst no significant differences are observed with IMA segments. There are no significant differences in endothelium-independent relaxant responses with either conduit (both p \> 0.05, B). Results are expressed as mean ± SEM.](oxim0303_0199_fig005){#F5}

![Endothelium-dependent relaxant responses (A) in internal mammary artery (IMA) and saphenous vein (SV) with current (n = 24) versus non-smokers (n = 40), and endothelium-independent relaxant responses (B) in IMA and SV with current (n = 16) versus non-smokers (n = 22) are displayed. Vessel segments are pre-contracted to a plateau using a sub-maximal dose of phenylephrine, then exposed to increasing concentrations of an endothelium-dependent (acetylcholine) or -independent (sodium nitroprusside) relaxant. Comparisons are made using unpaired repeated measures 2-way ANOVA and individual dose points are compared using Bonferroni post-hoc testing, with the indicated doses being significantly different from one another (p \< 0.05, compared to the other group). Differences in individual data points with IMA segments are noted below the curves, whilst differences with SV segments are indicated above the curves. The endothelium-dependent relaxant responses in IMA segments of non-smokers are significantly better than those of their smoking counterparts (p \< 0.05), whilst the responses in SV segments of current smokers are better than those of non-smokers (p \< 0.05, A). Endothelium-independent relaxant responses of SV are significantly better in current smokers versus non-smokers (p \< 0.05, B) whilst no significant differences are observed with IMA segments. Results are expressed as mean ± SEM.](oxim0303_0199_fig006){#F6}

![Endothelium-dependent relaxant responses (A) in internal mammary artery (IMA) and saphenous vein (SV) with current (n = 24) versus ex-smokers (n = 62). Endothelium-independent relaxant responses (B) in IMA and SV with current (n = 16) versus ex-smokers (n = 35) are displayed. Vessel segments are pre-contracted to a plateau using a sub-maximal dose of phenylephrine, then exposed to increasing concentrations of an endothelium-dependent (acetylcholine) or -independent (sodium nitroprusside) relaxant. Comparisons are made using unpaired repeated measures 2-way ANOVA, and individual dose points are compared using Bonferroni post-hoc testing, with the indicated doses being significantly different from one another (p \< 0.05, compared to the other group). The individual data point differences with SV segments are noted above the curve (B). The endothelium-dependent relaxant responses in IMA segments of ex-smokers are significantly better than those of their smoking counterparts (p \< 0.05, A) with no individual dose reaching significance, whilst there are no differences between the responses in SV segments (p \> 0.05). There are no significant differences in endothelium-independent relaxant responses in IMA segments (p \> 0.05), however the endothelium-independent relaxant responses in SV segments of current smokers were better than their ex-smoking counterparts (p \< 0.05, B). Results are expressed as mean ± SEM.](oxim0303_0199_fig007){#F7}

###### 

Breakdown of risk factors and medications by gender

  Characteristics               Male       Female
  ----------------------------- ---------- ----------
  **Age**                       29--82 y   44--79 y
  Total numbers                 103        23
  **Vascular Risk Factors**                
  Current smoker                21         3
  Ex-smoker                     55         7
  Non-smoker                    27         13
  Diabetic                      30         3
  Non-diabetic                  73         20
  Hypertensive                  54         13
  Non-hypertensive              49         10
  **Drug therapy**                         
  Anti-platelet                 102        23
  Statin                        97         22
  Beta-Blocker                  88         19
  ACE-Inhibitor                 79         16
  Calcium Channel Blocker       23         6
  Potassium Channel Activator   50         11
  Nitrate                       49         13
  Diuretic                      32         6

Demographic breakdown and distribution of pre-operative medications for included patients. ACE-inhibitor; angiotensin converting enzyme inhibitor.
